Ad is loading...
SPRB
Price
$0.49
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
110 days until earnings call
URGN
Price
$11.55
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
111 days until earnings call
Ad is loading...

SPRB vs URGN

Header iconSPRB vs URGN Comparison
Open Charts SPRB vs URGNBanner chart's image
Spruce Biosciences
Price$0.49
Change-$0.00 (-0.00%)
Volume$188.36K
CapitalizationN/A
UroGen Pharma
Price$11.55
Change-$0.00 (-0.00%)
Volume$549.66K
CapitalizationN/A
SPRB vs URGN Comparison Chart
Loading...
SPRB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
URGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
SPRB vs. URGN commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SPRB is a Hold and URGN is a Hold.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (SPRB: $0.49 vs. URGN: $11.55)
Brand notoriety: SPRB and URGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SPRB: 42% vs. URGN: 75%
Market capitalization -- SPRB: $20.24M vs. URGN: $502.6M
SPRB [@Biotechnology] is valued at $20.24M. URGN’s [@Biotechnology] market capitalization is $502.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SPRB’s FA Score shows that 1 FA rating(s) are green whileURGN’s FA Score has 0 green FA rating(s).

  • SPRB’s FA Score: 1 green, 4 red.
  • URGN’s FA Score: 0 green, 5 red.
According to our system of comparison, SPRB is a better buy in the long-term than URGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SPRB’s TA Score shows that 4 TA indicator(s) are bullish while URGN’s TA Score has 3 bullish TA indicator(s).

  • SPRB’s TA Score: 4 bullish, 5 bearish.
  • URGN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, SPRB is a better buy in the short-term than URGN.

Price Growth

SPRB (@Biotechnology) experienced а -5.76% price change this week, while URGN (@Biotechnology) price change was -2.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was -4.97%, and the average quarterly price growth was +4.04%.

Reported Earning Dates

SPRB is expected to report earnings on Mar 12, 2025.

URGN is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
URGN($503M) has a higher market cap than SPRB($20M). URGN YTD gains are higher at: -23.000 vs. SPRB (-83.242). SPRB has higher annual earnings (EBITDA): -39.02M vs. URGN (-97.82M). URGN has more cash in the bank: 250M vs. SPRB (60.1M). SPRB has less debt than URGN: SPRB (3.23M) vs URGN (122M). URGN has higher revenues than SPRB: URGN (89.4M) vs SPRB (7.1M).
SPRBURGNSPRB / URGN
Capitalization20M503M4%
EBITDA-39.02M-97.82M40%
Gain YTD-83.242-23.000362%
P/E RatioN/AN/A-
Revenue7.1M89.4M8%
Total Cash60.1M250M24%
Total Debt3.23M122M3%
FUNDAMENTALS RATINGS
URGN: Fundamental Ratings
URGN
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
78
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SPRBURGN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
SPRB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
URGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JOBY6.800.60
+9.68%
Joby Aviation
NTAP126.683.23
+2.62%
NetApp
ALHC12.100.15
+1.26%
Alignment Healthcare
TCRX3.94-0.18
-4.37%
TScan Therapeutics
CMAX0.67-0.07
-9.88%
CareMax

SPRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRB has been loosely correlated with MLEC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRB jumps, then MLEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRB
1D Price
Change %
SPRB100%
+0.20%
MLEC - SPRB
51%
Loosely correlated
-0.47%
IMRX - SPRB
50%
Loosely correlated
+3.43%
FATE - SPRB
45%
Loosely correlated
-6.76%
SCPX - SPRB
43%
Loosely correlated
-0.75%
GNFT - SPRB
39%
Loosely correlated
-1.62%
More